ArticleExperimental hematology & oncology2024

1q jumping translocation as a biomarker in myeloid malignancy: frequently mutated genes associated with bad prognosis and low survival.

Eitan Halper-Stromberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.